Fingerprint
Dive into the research topics of 'Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically